Ganglioside gm1 - Open Access .click

Results 231 to 240 of about 19,645 (254)

Some of the next articles are maybe not open access.

Neurologia i neurochirurgia polska, 1995
The study was taken up to compare the effect of treatment with ganglioside GM1 (Sygen, FIDIA-Italy) and typical treatment in the course of the disease. The study included 98 patients aged 40-82 in good or moderately good physical condition, with the ischaemic stroke confirmed by CT scan, in early stage of stroke (within 48 hours after onset).
A, Kuczyńska-Zardzewiały +3 more
openaire +1 more source

Domain-Dependent Modulation of PDGFRβ by Ganglioside GM1

Journal of Molecular Neuroscience, 2003
The regulation of receptor tyrosine kinases (RTKs) is important in several cellular events, including proliferation, differentiation, and apoptosis. Gangliosides are sialic acid-containing glycosphingolipids that can regulate RTK activity. The addition of ganglioside GM1 to the medium of Swiss 3T3 fibroblasts inhibits both platelet-derived growth ...
Janet L, Oblinger +3 more
openaire +2 more sources

GM1 Ganglioside in the Treatment of Parkinson's Disease^a

Annals of the New York Academy of Sciences, 1998
ABSTRACT: Since the early 1980s, numerous studies have been reported by laboratories around the world documenting the beneficial effects of GM1 ganglioside treatment on the damaged dopamine system in various animal and in vitro models. Based on the strength of these data, the first clinical studies designed to assess the efficacy and safety of chronic
openaire +2 more sources

HIGH LEVELS OF GM1-GANGLIOSIDE AND GM1-GANGLIOSIDE β-GALACTOSIDASE IN THE PAROTID GLAND